Secondary hemorrhagic shock to retroperitoneal spontaneous hematoma as a complication in pneumonia due to Covid-19

Authors

  • Marta López Doueil Assistant Anesthesiology Hospital Comarcal de Laredo-Laredo (Cantabria)
  • Mónica Galindo Palazuelos Assistant Anesthesiology Hospital Comarcal de Laredo-Laredo (Cantabria)
  • Nerea Alejandra Díaz Setién Assistant Anesthesiology Hospital Comarcal de Laredo-Laredo (Cantabria)
  • Nuria Arriaga Ocón Assistant Anesthesiology Hospital Comarcal de Laredo-Laredo (Cantabria)

DOI:

https://doi.org/10.30445/rear.v13i5.918

Keywords:

spontaneous iliopsoas muscle hematoma, hemorrhagic shock, pneumonia due to covid-19

Abstract

We present two clinical cases with pneumonia due to covid-19 which showed benignant progress after two weeks of treatment with hidroxychloroquine, antibiotics, corticosteroids and low-molecular-weight heparin anticoagulation according to protocol, and developed abrupt hypotension, decreased level of consciousness and blood loss anemia. After myocardial dysfunction was dismissed, an abdominal computed tomographic scan revealed an unilateral large hematoma of the iliopsoas muscle. Anticoagulation was stopped and fluids, vasoactive drugs and packed red blood cells were infused as needed.

Septic shock and organ dysfunction appear to occur in a significant proportion of critical illness covid-19 patients. An adequate index of suspicion of retroperitoneal hematoma is needed in covid-19 patients with shock and hemoglobin level drop as a complication of anticoagulation.

References

- Montero Feijoo A, Maseda E, Adalia Bartolomé R, Aguilar G, González de Castro R, et al. Recomendaciones prácticas para el manejo perioperatorio del paciente con sospecha o infección grave por coronavirus SARS-CoV-2. Rev Esp Anestesiol Reanim 2020;67(5):253-260

- Murthy S, Gomersall CD, Fowler RA. Care for critically ill patients with Covid-19. JAMA 2020; 323 (15):1499-1500

- Alhazzani W, Moller MH, Arabi YM, Loeb M, Gong MNg, et al. Surviving sepsis campaign: guidelines on the management of critically ill adults with coronavirus disease 2019 (COVID-19). Crit Care Med 2020. http//ccmjournal.org/10.1097/CCM.0000000000004363

- Clerkin KJ, Fried JA, Raikhelkar J, Sayer G, Griffin JM, et al. COVID-19 and Cardiovascular Disease. Circulation 2020;141:1648-1655

- Puzzitiello RN, Pagani NR, Moverman MA, Moon AS, Menendez MA, Ryan SP. Inflammatory and coagulative considerations for the management of orthopaedic trauma patients with covid-19: a review of the current evidence and our surgical experience. Journal of Orthop Trauma 2020. 10.1097/BOT.0000000000001842

- Bikdeli B, Madhavan MV, Jimenez D, Chuich T, Dreyfus I, et al. COVID-19 and trhombotic or thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up. J Am Coll Cardiol 2020;75:2950-2973

- Sanders JM, Monogue ML, Jodlowski TZ, Cutrell JB. Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19). JAMA 2020;323(18): 1824-1836

- González C, Penado S, Llata L, Valero C, Riancho JA. The clinical spectrum of retroperitoneal hematoma in Anticoagulated Patients. Medicine 2003;82: 257-262

Downloads

Published

2021-06-02

How to Cite

López Doueil, M., Galindo Palazuelos, M., Díaz Setién, N. A., & Arriaga Ocón, N. (2021).  Secondary hemorrhagic shock to retroperitoneal spontaneous hematoma as a complication in pneumonia due to Covid-19. Revista Electrónica AnestesiaR, 13(5). https://doi.org/10.30445/rear.v13i5.918

Issue

Vol. 13 No. 5 (2021): Revista Electrónica de AnestesiaR

Section

Clinical case reports

License

Copyright (c) 2021 Revista Electrónica AnestesiaR

Creative Commons License

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

Envío y derechos de autor